heparin: be given after blood transfusion

Property	Similarity
be given after blood transfusion	1.00
prevent blood from clotting	0.81
is administered before dialysis treatment	0.78
be absent in blood	0.78
be given to dialysis patients	0.78
prevents blood from clotting	0.77
be used in dialysis	0.76

0.66

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.81

Evidence: 0.94

Typical(heparin, be given after blood transfusion) ⋁

Evidence: 0.71

¬ Typical(heparin, prevent blood from clotting)

0.65

Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.78

Evidence: 0.94

Typical(heparin, be given after blood transfusion) ⋁

Evidence: 0.31

¬ Typical(heparin, be absent in blood)

0.64

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.78

Evidence: 0.91

Salient(heparin, be given after blood transfusion) ⋁

Evidence: 0.41

¬ Salient(heparin, be absent in blood)

0.64

Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.81

Evidence: 0.91

Salient(heparin, be given after blood transfusion) ⋁

Evidence: 0.77

¬ Salient(heparin, prevent blood from clotting)

0.64

Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.78

Evidence: 0.87

Plausible(heparin, be given after blood transfusion) ⋁

Evidence: 0.35

¬ Plausible(heparin, be absent in blood)

0.63

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.77

Evidence: 0.94

Typical(heparin, be given after blood transfusion) ⋁

Evidence: 0.54

¬ Typical(heparin, prevents blood from clotting)

0.63

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78

Evidence: 0.94

Typical(heparin, be given after blood transfusion) ⋁

Evidence: 0.89

¬ Typical(heparin, is administered before dialysis treatment)

0.63

Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.76

Evidence: 0.94

Typical(heparin, be given after blood transfusion) ⋁

Evidence: 0.43

¬ Typical(heparin, be used in dialysis)

0.63

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78

Evidence: 0.94

Typical(heparin, be given after blood transfusion) ⋁

Evidence: 0.94

¬ Typical(heparin, be given to dialysis patients)

0.63

Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.81

Evidence: 0.87

Plausible(heparin, be given after blood transfusion) ⋁

Evidence: 0.68

¬ Plausible(heparin, prevent blood from clotting)

0.62

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.78

Evidence: 0.91

Salient(heparin, be given after blood transfusion) ⋁

Evidence: 0.87

¬ Salient(heparin, is administered before dialysis treatment)

0.62

Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.78

Evidence: 0.91

Salient(heparin, be given after blood transfusion) ⋁

Evidence: 0.90

¬ Salient(heparin, be given to dialysis patients)

0.61

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.77

Evidence: 0.91

Salient(heparin, be given after blood transfusion) ⋁

Evidence: 0.71

¬ Salient(heparin, prevents blood from clotting)

0.61

Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.76

Evidence: 0.91

Salient(heparin, be given after blood transfusion) ⋁

Evidence: 0.63

¬ Salient(heparin, be used in dialysis)

0.61

Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77

Evidence: 0.87

Plausible(heparin, be given after blood transfusion) ⋁

Evidence: 0.57

¬ Plausible(heparin, prevents blood from clotting)

0.61

Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.76

Evidence: 0.87

Plausible(heparin, be given after blood transfusion) ⋁

Evidence: 0.49

¬ Plausible(heparin, be used in dialysis)

0.60

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.78

Evidence: 0.87

Plausible(heparin, be given after blood transfusion) ⋁

Evidence: 0.83

¬ Plausible(heparin, is administered before dialysis treatment)

0.59

Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.78

Evidence: 0.87

Plausible(heparin, be given after blood transfusion) ⋁

Evidence: 0.87

¬ Plausible(heparin, be given to dialysis patients)

0.51

Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.78

Evidence: 0.53

Remarkable(heparin, be given after blood transfusion) ⋁

Evidence: 0.50

¬ Remarkable(heparin, be given to dialysis patients)

0.50

Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.78

Evidence: 0.53

Remarkable(heparin, be given after blood transfusion) ⋁

Evidence: 0.55

¬ Remarkable(heparin, is administered before dialysis treatment)

0.48

Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.81

Evidence: 0.53

Remarkable(heparin, be given after blood transfusion) ⋁

Evidence: 0.65

¬ Remarkable(heparin, prevent blood from clotting)

0.46

Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.78

Evidence: 0.53

Remarkable(heparin, be given after blood transfusion) ⋁

Evidence: 0.67

¬ Remarkable(heparin, be absent in blood)

0.42

Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.77

Evidence: 0.53

Remarkable(heparin, be given after blood transfusion) ⋁

Evidence: 0.75

¬ Remarkable(heparin, prevents blood from clotting)

0.41

Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.76

Evidence: 0.53

Remarkable(heparin, be given after blood transfusion) ⋁

Evidence: 0.77

¬ Remarkable(heparin, be used in dialysis)

Parents	drug Weight: 0.72 , blood Weight: 0.57 , agent Weight: 0.56 , molecule Weight: 0.56
Siblings	acetaminophen Weight: 0.37 , fentanyl Weight: 0.37 , warfarin Weight: 0.36 , vancomycin Weight: 0.36

heparin: be given after blood transfusion

Related concepts

Related properties

Priors about this statement

Cues

Evidence

Clauses

Salient implies Plausible

Similarity expansion

Typical and Remarkable implies Salient

Typical implies Plausible